Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
CAR-T was developed to wipe out hard-to-treat blood cancers. But the cells that go bad in leukemias and lymphomas — immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback